JCO Early Release, published online ahead of print Jun 18 2007
Journal of Clinical Oncology, 10.1200/JCO.2007.12.3430
Bone Density in Breast Cancer: When to Intervene?
Julie R. Gralow
University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA

CiteULike Complore Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter What's this?
Related Articles
- Zoledronic Acid Prevents Cancer TreatmentInduced Bone Loss in Premenopausal Women Receiving Adjuvant Endocrine Therapy for Hormone-Responsive Breast Cancer: A Report From the Austrian Breast and Colorectal Cancer Study Group
Michael F.X. Gnant, Brigitte Mlineritsch, Gero Luschin-Ebengreuth, Stephan Grampp, Helmut Kaessmann, Marianne Schmid, Christian Menzel, Jutta Claudia Piswanger-Soelkner, Arik Galid, Martina Mittlboeck, Hubert Hausmaninger, and Raimund Jakesz
JCO 2007 25: 820-828
[Abstract]
[Full Text]
- Zoledronic Acid Inhibits Adjuvant LetrozoleInduced Bone Loss in Postmenopausal Women With Early Breast Cancer
Adam Brufsky, W. Graydon Harker, J. Thaddeus Beck, Robert Carroll, Elizabeth Tan-Chiu, Christopher Seidler, John Hohneker, Leo Lacerna, Stephanie Petrone, and Edith A. Perez
JCO 2007 25: 829-836
[Abstract]
[Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
M. Hickey, M. Peate, C.M. Saunders, and M. Friedlander
Breast cancer in young women and its impact on reproductive function
Hum. Reprod. Update,
May 1, 2009;
15(3):
323 - 339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Hershman, D. J. McMahon, K. D. Crew, S. Cremers, D. Irani, G. Cucchiara, L. Brafman, and E. Shane
Zoledronic Acid Prevents Bone Loss in Premenopausal Women Undergoing Adjuvant Chemotherapy for Early-Stage Breast Cancer
J. Clin. Oncol.,
October 10, 2008;
26(29):
4739 - 4745.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Greenspan, A. Brufsky, B. C. Lembersky, R. Bhattacharya, K. T. Vujevich, S. Perera, S. M. Sereika, and V. G. Vogel
Risedronate Prevents Bone Loss in Breast Cancer Survivors: A 2-Year, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
J. Clin. Oncol.,
June 1, 2008;
26(16):
2644 - 2652.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|